INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of “Buy” by Brokerages
Shares of INmune Bio, Inc. (NASDAQ:INMB – Get Free Report) have been assigned an average rating of “Buy” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. […]
Shares of INmune Bio, Inc. (NASDAQ:INMB – Get Free Report) have been assigned an average rating of “Buy” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. […]
